APA
de Bruijn R., Wimalasingham A., Szabados B., Stewart G. D., Welsh S. J., Kuusk T., Blank C., Haanen J., Klatte T., Staehler M., Powles T. & Bex A. (20201204). Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. : European urology oncology.
Chicago
de Bruijn Roderick, Wimalasingham Akhila, Szabados Bernadett, Stewart Grant D, Welsh Sarah J, Kuusk Teele, Blank Christian, Haanen John, Klatte Tobias, Staehler Michael, Powles Thomas and Bex Axel. 20201204. Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. : European urology oncology.
Harvard
de Bruijn R., Wimalasingham A., Szabados B., Stewart G. D., Welsh S. J., Kuusk T., Blank C., Haanen J., Klatte T., Staehler M., Powles T. and Bex A. (20201204). Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. : European urology oncology.
MLA
de Bruijn Roderick, Wimalasingham Akhila, Szabados Bernadett, Stewart Grant D, Welsh Sarah J, Kuusk Teele, Blank Christian, Haanen John, Klatte Tobias, Staehler Michael, Powles Thomas and Bex Axel. Deferred Cytoreductive Nephrectomy Following Presurgical Vascular Endothelial Growth Factor Receptor-targeted Therapy in Patients with Primary Metastatic Clear Cell Renal Cell Carcinoma: A Pooled Analysis of Prospective Trial Data. : European urology oncology. 20201204.